severe combined immunodeficiency scid also known swisstype agammaglobulinemia rare genetic disorder characterized disturbed development functional cells b cells caused numerous genetic mutations result differing clinical scid involves defective antibody response due either direct involvement b lymphocytes improper b lymphocyte activation due nonfunctional thelper consequently arms b cells cells adaptive immune system impaired due defect one several possible genes scid severe form primary least nine different known genes mutations lead form also known bubble boy disease bubble baby disease victims extremely vulnerable infectious diseases david vetter become famous living sterile environment scid result immune system highly compromised considered almost absent scid patients usually affected severe bacterial viral fungal infections early life often present interstitial lung disease chronic diarrhea failure ear infections recurrent pneumocystis jirovecii previously carinii pneumonia profuse oral candidiasis commonly occur babies untreated usually die within one year due severe recurrent infections unless undergone successful hematopoietic stem cell transplantation gene therapy clinical type mhc class ii expressed cell surface antigen presenting cells autosomal recessive mhcii gene regulatory proteins altered mhcii protein early diagnosis scid usually difficult due need advanced screening techniques several symptoms may indicate possibility scid child family history infant death chronic coughs hyperinflated lungs persistent infections full blood lymphocyte count often considered reliable manner diagnosing scid higher lymphocyte counts childhood may influence results clinical diagnosis based genetic defects also possible diagnostic procedure implemented scid detected sequencing fetal dna known history disease exists otherwise scid diagnosed six months age usually indicated recurrent infections delay detection newborns carry mothers antibodies first weeks life scid babies look normalcitation needed several countries test newborns scid part routine newborn screening september known percentage newborns screened increased throughout world united states europe latin america middle east north africa asiapacific central america introduction newborn screenings genetic testing many countries allowed early detection treatment development severe infections progressively improved fiveyear survival rate newborns scid around states performing screening scid newborns using realtime quantitative pcr measure concentration tcell receptor excision common treatment scid bone marrow transplantation successful using either matched related unrelated donor halfmatched donor would either parent halfmatched type transplant called haploidentical haploidentical bone marrow transplants require donor marrow depleted mature cells avoid occurrence graftversushost disease consequently functional immune system takes longer develop patient receives haploidentical bone marrow transplant compared patient receiving matched transplant first reported case successful transplant spanish child patient interned memorial sloan kettering cancer center new york david vetter original bubble boy one first transplantations also eventually died unscreened virus epsteinbarr tests available time newly transplanted bone marrow sister unmatched bone marrow donor today transplants done first three months life high success rate physicians also success utero transplants done child born also using cord blood rich stem cells utero transplants allow fetus develop functional immune system sterile environment however complications gvhd would difficult detect treat recently gene therapy attempted alternative bone marrow transplant transduction missing gene hematopoietic stem cells using viral vectors tested ada scid xlinked scid fouryearold ashanthi desilva became first patient undergo successful gene therapy researchers collected samples desilvas blood isolated white blood cells used retrovirus insert healthy adenosine deaminase ada gene cells injected back body began express normal enzyme augmented weekly injections ada corrected deficiency however concurrent treatment ada injections may impair success gene therapy since transduced cells selective advantage proliferate untransduced cells survive presence injected gene therapy success resulted scid patients functional immune system trials stopped discovered two ten patients one trial developed leukemia resulting insertion genecarrying retrovirus near oncogene four ten patients developed work aimed improving gene therapy focusing modifying viral vector reduce likelihood oncogenesis using zincfinger nucleases target gene leukemia cases yet seen trials adascid involve gamma c gene may oncogenic expressed retrovirus treatments ashanthi desilva considered gene therapys first success around patients treated either adascid using retroviruses vectors previously mentioned occurrence leukemia cases forced researchers make changes improve new method using altered version hiv virus lentivirus vector reported treatment eight children method used children adascid obtaining positive results also noncurative methods treating scid reverse isolation involves use laminar air flow mechanical barriers avoid physical contact others order isolate patient harmful pathogens present external another noncurative treatment patients adascid enzyme replacement therapy patient injected polyethyleneglycolcoupled adenosine deaminase pegada metabolizes toxic substrates ada enzyme prevents treatment pegada may used restore cell function short term enough clear existing infections proceeding curative treatment bone marrow commonly quoted figure prevalence scid around one births although regarded underestimate true estimates predict prevalence rate high one live figure one live births reported due particular genetic nature scid higher prevalence may found certain regions associated cultures higher rates consanguineous mating moroccan study reported consanguineous parenting observed families moroccan scid recent studies indicate one every children navajo population inherit severe combined immunodeficiency condition significant cause illness death among navajo ongoing research reveals similar genetic pattern among related apache scid mice still used disease vaccine transplant research especially animal models testing safety new vaccines therapeutic agents people weakened immune system scid mice also serve useful animal model study human immune system interactions disease infections example normal strains mice lethally irradiated killing rapidly dividing cells mice receive bone marrow transplantation scid donors allowing engraftment human peripheral blood mononuclear cells pbmc occur method used study whether celllacking mice perform hematopoiesis receiving human recessive gene clinical signs similar human condition affects arabian horse condition remains fatal disease horse inevitably succumbs opportunistic infection within first four six months however carriers affected disease detected dna test therefore careful breeding practices avoid risk affected foal another animal wellcharacterized scid pathology dog two known forms xlinked scid basset hounds similar ontology xscid autosomal recessive form seen one line jack russell terriers similar scid arabian horses peripheral purine nucleoside phosphorylase deficiency httpsenwikipediaorgwikialymphocytosis